Cargando…

Precision-engineering of subunit vaccine particles for prevention of infectious diseases

Vaccines remain the best approach for the prevention of infectious diseases. Protein subunit vaccines are safe compared to live-attenuated whole cell vaccines but often show reduced immunogenicity. Subunit vaccines in particulate format show improved vaccine efficacy by inducing strong immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuxiong, Pounraj, Saranya, Sivakumaran, Nivethika, Kakkanat, Anjali, Sam, Gayathri, Kabir, Md. Tanvir, Rehm, Bernd H. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935699/
https://www.ncbi.nlm.nih.gov/pubmed/36817419
http://dx.doi.org/10.3389/fimmu.2023.1131057
_version_ 1784890073882296320
author Chen, Shuxiong
Pounraj, Saranya
Sivakumaran, Nivethika
Kakkanat, Anjali
Sam, Gayathri
Kabir, Md. Tanvir
Rehm, Bernd H. A.
author_facet Chen, Shuxiong
Pounraj, Saranya
Sivakumaran, Nivethika
Kakkanat, Anjali
Sam, Gayathri
Kabir, Md. Tanvir
Rehm, Bernd H. A.
author_sort Chen, Shuxiong
collection PubMed
description Vaccines remain the best approach for the prevention of infectious diseases. Protein subunit vaccines are safe compared to live-attenuated whole cell vaccines but often show reduced immunogenicity. Subunit vaccines in particulate format show improved vaccine efficacy by inducing strong immune responses leading to protective immunity against the respective pathogens. Antigens with proper conformation and function are often required to induce functional immune responses. Production of such antigens requiring post-translational modifications and/or composed of multiple complex domains in bacterial hosts remains challenging. Here, we discuss strategies to overcome these limitations toward the development of particulate vaccines eliciting desired humoral and cellular immune responses. We also describe innovative concepts of assembling particulate vaccine candidates with complex antigens bearing multiple post-translational modifications. The approaches include non-covalent attachments (e.g. biotin-avidin affinity) and covalent attachments (e.g. SpyCatcher-SpyTag) to attach post-translationally modified antigens to particles.
format Online
Article
Text
id pubmed-9935699
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99356992023-02-18 Precision-engineering of subunit vaccine particles for prevention of infectious diseases Chen, Shuxiong Pounraj, Saranya Sivakumaran, Nivethika Kakkanat, Anjali Sam, Gayathri Kabir, Md. Tanvir Rehm, Bernd H. A. Front Immunol Immunology Vaccines remain the best approach for the prevention of infectious diseases. Protein subunit vaccines are safe compared to live-attenuated whole cell vaccines but often show reduced immunogenicity. Subunit vaccines in particulate format show improved vaccine efficacy by inducing strong immune responses leading to protective immunity against the respective pathogens. Antigens with proper conformation and function are often required to induce functional immune responses. Production of such antigens requiring post-translational modifications and/or composed of multiple complex domains in bacterial hosts remains challenging. Here, we discuss strategies to overcome these limitations toward the development of particulate vaccines eliciting desired humoral and cellular immune responses. We also describe innovative concepts of assembling particulate vaccine candidates with complex antigens bearing multiple post-translational modifications. The approaches include non-covalent attachments (e.g. biotin-avidin affinity) and covalent attachments (e.g. SpyCatcher-SpyTag) to attach post-translationally modified antigens to particles. Frontiers Media S.A. 2023-02-03 /pmc/articles/PMC9935699/ /pubmed/36817419 http://dx.doi.org/10.3389/fimmu.2023.1131057 Text en Copyright © 2023 Chen, Pounraj, Sivakumaran, Kakkanat, Sam, Kabir and Rehm https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Chen, Shuxiong
Pounraj, Saranya
Sivakumaran, Nivethika
Kakkanat, Anjali
Sam, Gayathri
Kabir, Md. Tanvir
Rehm, Bernd H. A.
Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title_full Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title_fullStr Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title_full_unstemmed Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title_short Precision-engineering of subunit vaccine particles for prevention of infectious diseases
title_sort precision-engineering of subunit vaccine particles for prevention of infectious diseases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935699/
https://www.ncbi.nlm.nih.gov/pubmed/36817419
http://dx.doi.org/10.3389/fimmu.2023.1131057
work_keys_str_mv AT chenshuxiong precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT pounrajsaranya precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT sivakumarannivethika precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT kakkanatanjali precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT samgayathri precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT kabirmdtanvir precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases
AT rehmberndha precisionengineeringofsubunitvaccineparticlesforpreventionofinfectiousdiseases